GAO: Rise in Drug Shortages Harming Patients

A pharmacist pours Truvada pills back into the bottle at Jack's Pharmacy on November 23, 2010 in San Anselmo, California.
National Journal
Clara Ritger
Add to Briefcase
See more stories about...
Clara Ritger
Feb. 10, 2014, 1:52 p.m.

The num­ber of drug short­ages has quad­rupled in the past five years, for­cing doc­tors and phar­macists to delay or ra­tion care, as life-sav­ing med­ic­a­tions re­main in short sup­ply, ac­cord­ing to the Gov­ern­ment Ac­count­ab­il­ity Of­fice on Monday.

There were 456 drug short­ages in 2012, and the trend was con­tinu­ing, with an­oth­er 361 drug short­ages re­por­ted by the middle of 2013, ac­cord­ing to the GAO re­port.

Drug-qual­ity is­sues and man­u­fac­tur­ing delays or shut­downs re­lated to qual­ity ac­coun­ted for 70 per­cent of drug short­ages re­por­ted between Jan. 1, 2011, and June 30, 2013, ac­cord­ing to the re­port.

The scarcity of cer­tain drugs in the mar­ket has jeop­ard­ized the abil­ity of care pro­viders to sta­bil­ize trauma vic­tims, con­trol pain dur­ing sur­gery, and treat heart dis­ease, said Mar­cia Crosse, GAO’s dir­ect­or of health care, at a con­gres­sion­al hear­ing on the re­port.

“The large num­ber of short­ages re­por­ted to the FDA sug­gests the mar­ket is still at risk of sup­ply dis­rup­tions,” Crosse said.

The Food and Drug Ad­min­is­tra­tion is re­spons­ible for over­see­ing drug qual­ity-prob­lems and work­ing with man­u­fac­tur­ers to rem­edy short­ages. Con­gress gran­ted the FDA great­er over­sight powers in 2012 after it passed the Food and Drug Ad­min­is­tra­tion Safety and In­nov­a­tion Act, re­quir­ing man­u­fac­tur­ers to no­ti­fy the agency of short­ages and re­quir­ing the agency to main­tain short­age data­bases and cre­ate ac­tion plans to solve them.

GAO cred­ited the FDA with mak­ing pro­gress in its goal to in­crease the avail­ab­il­ity of drugs, par­tic­u­larly gen­er­ics, in the face of short­ages. The FDA’s ef­forts to get drugs back on the mar­ket in­clude reg­u­lat­ory flex­ib­il­ity and ex­ped­ited re­views of new drugs.

While the num­ber of over­all drug short­ages re­mains high, the num­ber of new drug short­ages is fall­ing. There were 195 new short­ages in 2012, down from 255 in 2011.

“Our next task is to un­der­stand those longer-dur­a­tion short­ages,” said Douglas Throck­mor­ton, deputy dir­ect­or of reg­u­lat­ory pro­grams at the FDA.

Roughly 64 per­cent of new drug short­ages — 722 of the 1,132 re­por­ted to the FDA between Janu­ary 2007 and June 2013 — las­ted less than one year. But 14 per­cent las­ted more than two years, and some as long as four or more.

GAO re­com­mends that the FDA im­prove its data­base of drug short­ages and use the in­form­a­tion to ana­lyze trends and identi­fy risk factors to pre­vent fu­ture de­fi­cien­cies.

What We're Following See More »
PLANS TO CURB ITS POWER
Pruitt Confirmed As EPA Head
2 days ago
BREAKING
WOULD HAVE REPLACED FLYNN
Harward Turns Down NSC Job
2 days ago
THE LATEST

"Ret. Vice Adm. Bob Harward turned down President Donald Trump's offer to be national security adviser Thursday, depriving the administration of a top candidate for a critical foreign policy post days after Trump fired Michael Flynn." Among the potential reasons: his family, his lack of assurances that he could build his own team, and that "the White House seems so chaotic."

Source:
REVERSES OBAMA RULE
House Votes to Let States Block Planned Parenthood Funds
3 days ago
THE LATEST

"The House passed a resolution Thursday re-opening the door for states to block Planned Parenthood from receiving some federal funds. The measure, which passed 230-188, would reverse a last-minute rule from the Obama administration that said conservative states can't block the women's health and abortion provider from receiving family planning dollars under the Title X program."

Source:
FORMER PROSECUTOR
Alexander Acosta to Get Nod for Labor
3 days ago
THE LATEST
12:30 PRESS CONFERENCE
New Labor Secretary Announcement Coming
3 days ago
BREAKING
×
×

Welcome to National Journal!

You are currently accessing National Journal from IP access. Please login to access this feature. If you have any questions, please contact your Dedicated Advisor.

Login